Molecular Advances in Glomerular Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 8743
Special Issue Editors
Interests: glomerulonephritis; nephrotic syndrome genetics and mechanisms; therapy of nephrotic syndrome; systemic lupus erythematosus; lupus nephritis; mechanisms for autoimmunity
Interests: autoimmunity clinical trials rheumatic diseases; cell adhesion renal rheumatoid arthritis; autoimmune disease autoantibodies clinical immunology
Special Issue Information
Dear Colleagues,
Glomerular diseases are a heterogeneous group of inflammatory diseases that represent an important cause of chronic morbidity, potentially evolving to renal failure. Pathology features, specific mechanisms causing glomerular damage, and association with extra-renal conditions represent the basis for a general classification that has clinical implications. Renal pathology varies from minimal lesions to diffuse glomerular proliferation, thickening of the basement membrane, and alteration of the microvasculature; circulating autoantibodies versus intrinsic or implanted antigens are often involved as a starting mechanism, and deposition of elements of the complement cascade may be involved as a main pathogenetic feature. Variable degrees of proteinuria, including nephrotic syndrome and hematuria, are the classical hallmarks that aggregate different conditions.
Evolutions in the pathogenesis of 'glomerular diseases' are sound and include the recognition of new autoantibodies causative of primary and secondary forms (Membranous nephropathy, Lupus nephritis), regulatory cells involved in inflammation, and other mechanisms of direct damage. Therapies do not witness those evolutions and have been substantially based, for many years, on the same drugs (steroids, CNI, mycophenolate mofetyl, anti-CD20).
Recognizing molecular factors would help us to implement potential targets of therapeutics, which is of particular interest in an era in which many new drugs targeting specific actors of inflammation, such as T/B cells, interleukins, intracellular factors, etc., have been developed and are already utilized with success in other inflammatory conditions.
Dr. Gian Marco Ghiggeri
Dr. Renato Alberto Sinico
Dr. Andrea Angeletti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glomerulonephritis
- proteinuria
- autoantibodies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
